Hansa Biopharma AB (publ) (STO: HNSA)
Sweden
· Delayed Price · Currency is SEK
30.60
+0.62 (2.07%)
Nov 20, 2024, 5:29 PM CET
Hansa Biopharma AB Employees
Hansa Biopharma AB had 168 employees as of December 31, 2023. The number of employees increased by 18 or 12.00% compared to the previous year.
Employees
168
Change (1Y)
18
Growth (1Y)
12.00%
Revenue / Employee
1.40M SEK
Profits / Employee
-4.85M SEK
Market Cap
2.08B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca PLC | 89,900 |
Swedish Orphan Biovitrum AB (publ) | 1,772 |
Sectra AB (publ) | 1,204 |
Getinge AB (publ) | 11,739 |
Camurus AB (publ) | 213 |
Medicover AB (publ) | 45,316 |
Elekta AB (publ) | 4,718 |
BioArctic AB (publ) | 88 |
Hansa Biopharma AB News
- 22 days ago - Hansa Biopharma to Attend Truist Securities BioPharma Symposium - PRNewsWire
- 4 weeks ago - Hansa Biopharma AB (publ) (HNSBF) Q3 2024 Results Conference Call Transcript - Seeking Alpha
- 4 weeks ago - Hansa Biopharma AB (publ) 2024 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 5 weeks ago - Hansa Biopharma Reports Third Quarter and Interim January - September 2024 Financial Results - PRNewsWire
- 6 weeks ago - Hansa Biopharma's HNSA-5487 Achieved Rapid and Highly Robust IgG Reduction by More Than 95% and Clear Redosing Potential in First-in-Human Trial - PRNewsWire
- 2 months ago - Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference - PRNewsWire
- 3 months ago - Hansa Biopharma Announces Departure of Chief Commercial Officer, Matthew Shaulis - PRNewsWire
- 4 months ago - Hansa Biopharma AB (publ) (HNSBF) Q2 2024 Earnings Call Transcript - Seeking Alpha